Long-term kidney transplant outcomes in primary glomerulonephritis: Analysis from the ERA-EDTA registry

Transplantation

Volumn 100, Issue 9, 2016, Pages 1955-1962

  Pippias, Maria ^a   Stel, Vianda S ^a   Aresté Fosalba, Nuria ^b   Couchoud, Cécile ^c   Fernandez Fresnedo, Gema ^d   Finne, Patrik ^e,f   Heaf, James G ^g   Hoitsma, Andries ^h   De Meester, Johan ⁱ   Pálsson, Runolfur ^j,k   Ravani, Pietro ^l   Segelmark, Mårten ^m   Traynor, Jamie P ⁱ   Reisæter, Anna V ⁿ   Caskey, Fergus J ^o,p   Jager, Kitty J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^c AGENCE DE LA BIOMÉDECINE   (France)

^d HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^f Finnish Registry for Kidney Diseases   (Finland)

^g UNIVERSITY OF COPENHAGEN   (Denmark)

^h RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ Dutch Speaking Belgian Renal Registry ^*  (United Kingdom)

^j LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^k UNIVERSITY OF ICELAND   (Iceland)

^l UNIVERSITY OF CALGARY   (Canada)

^m LINKÖPING UNIVERSITY   (Sweden)

ⁿ OSLO UNIVERSITY HOSPITAL   (Norway)

^o SOUTHMEAD HOSPITAL   (United Kingdom)

^p UNIVERSITY OF BRISTOL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CADAVER KIDNEY; CONTROLLED STUDY; DEATH; DEATH ADJUSTED GRAFT FAILURE; DEATH ADJUSTED GRAFT SURVIVAL; DIALYSIS; DISEASE REGISTRY; FEMALE; FOCAL GLOMERULOSCLEROSIS; FOLLOW UP; GENDER; GLOMERULONEPHRITIS; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY ALLOGRAFT; KIDNEY DONOR; KIDNEY POLYCYSTIC DISEASE; MAJOR CLINICAL STUDY; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS TYPE I; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS TYPE II; MEMBRANOUS GLOMERULONEPHRITIS; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; SURVIVAL RATE; SURVIVAL TIME; TREATMENT DURATION; TREATMENT RESPONSE; ADVERSE EFFECTS; ALLOGRAFT; CLINICAL TRIAL; COMPARATIVE STUDY; EUROPE; KAPLAN MEIER METHOD; KIDNEY TRANSPLANTATION; LIVING DONOR; MIDDLE AGED; MULTICENTER STUDY; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; PROPORTIONAL HAZARDS MODEL; RECURRENT DISEASE; REGISTER; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME;

ADULT; ALLOGRAFTS; EUROPE; FEMALE; GLOMERULONEPHRITIS; GRAFT SURVIVAL; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; PROPORTIONAL HAZARDS MODELS; RECURRENCE; REGISTRIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84947791497     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000962     Document Type: Article

References (31)

1. Matas AJ, Smith JM, Skeans MA, et al. OPTN/SRTR 2011 Annual Data Report: kidney. Am J Transplant. 2013;13(Suppl 1):11-46.
2. Briganti EM, Russ GR, McNeil JJ, et al. Risk of renal allograft loss from recurrent glomerulonephritis. N Engl JMed. 2002;347:103-109.
3. Chang SH, Russ GR, Chadban SJ, et al. Trends in kidney transplantation in Australia and New Zealand, 1993-2004. Transplantation. 2007;84: 611-618.
4. Chadban S. Glomerulonephritis recurrence in the renal graft. J Am Soc Nephrol. 2001;12:394-402.
5. Choy BY, Chan TM, Lo SK, et al. Renal transplantation in patients with primary immunoglobulin A nephropathy. Nephrol Dial Transplant. 2003;18: 2399-2404.
6. Floege J. Recurrent glomerulonephritis following renal transplantation: An update. Nephrol Dial Transplant. 2003;18:1260-1265.
7. Ponticelli C, Traversi L, Feliciani A, et al. Kidney transplantation in patients with IgA mesangial glomerulonephritis. Kidney Int. 2001;60: 1948-1954.
8. European Renal Best Practice Transplantation Guideline Development Group. ERBP Guideline on the Management and Evaluation of the Kidney Donor and Recipient. Nephrol Dial Transplant. 2013;28(Suppl 2):ii1-ii71.
9. Andrews PA, Burnapp L, Manas D, et al. British Transplantation Society; Renal Association. Summary of the British Transplantation Society/Renal Association U.K. guidelines for living donor kidney transplantation. Transplantation. 2012;93:666-673.
10. Karam GKT, Alcaraz A, Aki FT, et al. Guidelines on Renal Transplantation. The European Association of Urology. Retrieved from: http://wwwuroweborg/gls/pdf/26-Renal-Transplant-LRpdf, 2009.
11. Knoll G, Cockfield S, Blydt-Hansen T, et al. Kidney Transplant Working Group of the Canadian Society of Transplantation. Canadian Society of Transplantation consensus guidelines on eligibility for kidney transplantation. CMAJ. 2005;173:1181-1184.
12. Pippias M, Stel VS, Abad Diez JM, et al. Renal replacement therapy in Europe: A summary of the 2012 ERA-EDTA Registry Annual Report. Clin Kidney J. 2015;8:248-261.
13. Moroni G, Longhi S, Quaglini S, et al. The long-term outcome of renal transplantation of IgA nephropathy and the impact of recurrence on graft survival. Nephrol Dial Transplant. 2013;28:1305-1314.
14. Noordzij M, Leffondré K, van Stralen KJ, et al. When do we need competing risks methods for survival analysis in nephrology? Nephrol Dial Transplant. 2013;28:2670-2677.
15. Andresdottir MB, Haasnoot GW, Doxiadis II, et al. Exclusive characteristics of graft survival and risk factors in recipients with immunoglobulin A nephropathy: A retrospective analysis of registry data. Transplantation. 2005;80:1012-1018.
16. Karakayali FY, Ozdemir H, Kivrakdal S, et al. Recurrent glomerular diseases after renal transplantation. Transplant Proc. 2006;38:470-472.
17. Wang AY, Lai FM, Yu AW, et al. Recurrent IgA nephropathy in renal transplant allografts. Am J Kidney Dis. 2001;38:588-596.
18. Andresdottir MB, Assmann KJ, Hoitsma AJ, et al. Recurrence of type I membranoproliferative glomerulonephritis after renal transplantation: Analysis of the incidence, risk factors, and impact on graft survival. Transplantation. 1997;63:1628-1633.
19. Lorenz EC, Sethi S, Leung N, et al. Recurrent membranoproliferative glomerulonephritis after kidney transplantation. Kidney Int. 2010;77: 721-728.
20. Angelo JR, Bell CS, Braun MC. Allograft failure in kidney transplant recipients with membranoproliferative glomerulonephritis. Am J Kidney Dis. 2011;57:291-299.
21. Nasr SH, Valeri AM, Appel GB, et al. Dense deposit disease: clinicopathologic study of 32 pediatric and adult patients. Clin J Am Soc Nephrol. 2009;4:22-32.
22. Little MA, Dupont P, Campbell E, et al. Severity of primary MPGN, rather than MPGN type, determines renal survival and post-transplantation recurrence risk. Kidney Int. 2006;69:504-511.
23. Beck LH Jr, Bonegio RG, Lambeau G, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009;361:11-21.
24. Debiec H, Martin L, Jouanneau C, et al. Autoantibodies specific for the phospholipase A2 receptor in recurrent and De Novo membranous nephropathy. Am J Transplant. 2011;11:2144-2152.
25. Andrésdóttir MB, Wetzels JF. Increased risk of recurrence ofmembranous nephropathy after related donor kidney transplantation. Am J Transplant. 2012;12:265-266.
26. Pardon A, Audard V, Caillard S, et al. Risk factors and outcome of focal and segmental glomerulosclerosis recurrence in adult renal transplant recipients. Nephrol Dial Transplant. 2006;21:1053-1059.
27. Abbott KC, Sawyers ES, Oliver JD 3rd, et al. Graft loss due to recurrent focal segmental glomerulosclerosis in renal transplant recipients in the United States. Am J Kidney Dis. 2001;37:366-373.
28. Nehus EJ, Goebel JW, Succop PS, et al. Focal segmental glomerulosclerosis in children: multivariate analysis indicates that donor type does not alter recurrence risk. Transplantation. 2013;96:550-554.
29. Maas RJ, Deegens JK, van den Brand JA, et al. A retrospective study of focal segmental glomerulosclerosis: clinical criteria can identify patients at high risk for recurrent disease after first renal transplantation. BMC Nephrol. 2013;14:47.
30. Baum MA, Stablein DM, Panzarino VM, et al. Loss of living donor renal allograft survival advantage in children with focal segmental glomerulosclerosis. Kidney Int. 2001;59:328-333.
31. Jacquet A, Pallet N, Kessler M, et al. Outcomes of renal transplantation in patients with autosomal dominant polycystic kidney disease: A nationwide longitudinal study. Transpl Int. 2011;24:582-587.